PMC Articles for MedGen (Select 1648585) - PMC

Result Filters

Links from MedGen

Items: 1 to 20 of 99

<< First< Prev

Page of 5

Select item 111593691.

Promoter hypermethylation of DAP‐kinase is associated with poor survival in primary biliary tract carcinoma patients

Tomohiro Tozawa, Gen Tamura, Teiichiro Honda, Shin‐ichi Nawata, Wataru Kimura, Naohiko Makino, Sumio Kawata, Tamotsu Sugai, Takayuki Suto, Teiichi Motoyama

Cancer Sci. 2004 Sep; 95(9): 736–740. Published online 2005 Aug 19. doi: 10.1111/j.1349-7006.2004.tb03254.x

PMCID:: PMC11159369

Abstract Article PDF–333K

Select item 111592502.

Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma

Hidenori Ojima, Yae Kanai, Motoki Iwasaki, Nobuyoshi Hiraoka, Kazuaki Shimada, Tsuyoshi Sano, Yoshihiro Sakamoto, Minoru Esaki, Tomoo Kosuge, Michiie Sakamoto, Setsuo Hirohashi

Cancer Sci. 2009 Jan; 100(1): 62–70. Published online 2008 Nov 25. doi: 10.1111/j.1349-7006.2008.01009.x

PMCID:: PMC11159250

Abstract Article PDF–280K

Select item 111589353.

Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment

Hidenori Ojima, Daitaro Yoshikawa, Yoshihiro Ino, Hiroko Shimizu, Masashi Miyamoto, Akiko Kokubu, Nobuyoshi Hiraoka, Noriaki Morofuji, Tadashi Kondo, Hiroaki Onaya, Takuji Okusaka, Kazuaki Shimada, Yoshihiro Sakamoto, Minoru Esaki, Satoshi Nara, Tomoo Kosuge, Setsuo Hirohashi, Yae Kanai, Tatsuhiro Shibata

Cancer Sci. 2010 Apr; 101(4): 882–888. Published online 2009 Dec 8. doi: 10.1111/j.1349-7006.2009.01462.x

PMCID:: PMC11158935

Abstract Article PDF–634K

Select item 109924554.

Effectiveness and safety of radiotherapy plus programmed death-1 inhibitors and lenvatinib in patients with advanced biliary tract carcinoma: a real-world study

Yunchao Wang, Xiaobo Yang, Yanyu Wang, Jingnan Xue, Nan Zhang, Xu Yang, Ning Cong, Junwei Zhang, Chengpei Zhu, Longhao Zhang, Xiaorong Hou, Haitao Zhao

Cancer Immunol Immunother. 2023 Jul; 72(7): 2197–2204. Published online 2023 Mar 1. doi: 10.1007/s00262-023-03399-2

PMCID:: PMC10992455

Abstract Article PDF–816K

Select item 106013155.

Analysis of the efficacy and factors influencing survival of adjuvant radiotherapy for stage II-III biliary tract carcinoma

Yan-Ling Guo, Jia-Xing Guo, Jian-Guo Zhao, Ying-Na Bao

World J Surg Oncol. 2023; 21: 339. Published online 2023 Oct 26. doi: 10.1186/s12957-023-03209-0

PMCID:: PMC10601315

Abstract Article PDF–1.5M

Select item 105468106.

Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma

Sri Harsha Tella, Nathan Foster, Shi Qian, Tran Nguyen, Mitesh J Borad, Robert R McWilliams, Steven R Alberts, Wen Wee Ma, Sakti Chakrabarti, Briant Fruth, Jaclynn Wessling, Mindy Hartgers, Leslie Washburn, Martin E Fernandez-Zapico, Tara L Hogenson, Henry Pitot, Zhaohui Jin, Amit Mahipal

Oncologist. 2023 Oct; 28(10): 917–e966. Published online 2023 Jun 20. doi: 10.1093/oncolo/oyad144

PMCID:: PMC10546810

Abstract Article PDF–1.4M

Select item 104699847.

Spatial Patterns of Gallbladder and Biliary Tract Carcinoma in China From 1990 to 2019: An Analysis at the Provincial Level

Chuanbo Xie, Di Shi, Hualiang Lin, Yuying Liu, Wei Liu, Peng Yin

Cureus. 2023 Aug; 15(8): e42796. Published online 2023 Aug 1. doi: 10.7759/cureus.42796

PMCID:: PMC10469984

Abstract Article PDF–993K

Select item 104697138.

Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma

Yunfeng Li, Chaochao Tan, Xinmin Yin, Siwei Zhu, Rongyao Cai, Chunhong Liao, Yifei Wu, Qihong Zeng, Chengzhi Cai, Wang Xie, Xiangyu He, Hao‐quan Wen, Guomin Lin, Qingqing He, Tingting He, Peng Gu, Chang‐jun Liu

Cancer Med. 2023 Aug; 12(15): 16076–16086. Published online 2023 Jun 21. doi: 10.1002/cam4.6261

PMCID:: PMC10469713

Abstract Article PDF–3.0M

Select item 101864979.

A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line treatment of advanced biliary tract carcinoma

Jie Zeng, Jie Ma, Zhiming Zeng, Lihua Yang, Yanfeng Jiang, Ning Mo, Fuchao Ma, Cuizhen Liu, Rong Li, Jing Tang, Shanyu Qin, Haixing Jiang

J Gastrointest Oncol. 2023 Apr 29; 14(2): 758–767. Published online 2023 Apr 26. doi: 10.21037/jgo-23-218

PMCID:: PMC10186497

Abstract Article PDF–319K

Select item 965466910.

Pathologies of Precursor Lesions of Biliary Tract Carcinoma

Yasuni Nakanuma, Yuko Kakuda, Takashi Sugino, Yasunori Sato, Yuki Fukumura

Cancers (Basel) 2022 Nov; 14(21): 5358. Published online 2022 Oct 30. doi: 10.3390/cancers14215358

PMCID:: PMC9654669

Abstract Article PDF–2.1M

Select item 963548111.

PD-1-mAb Plus Regimen in the First and Second Lines of Advanced and Unresectable Biliary Tract Carcinoma: A Real-World, Multicenter Retrospective Analysis

Fang Wang, Feng-Hua Wang, Kaiyu Sun, Chang Jiang, Sui Peng, Li-Xia Xu, Ming Kuang, Gui-Fang Guo, Shu-Ling Chen

J Inflamm Res. 2022; 15: 6031–6046. Published online 2022 Oct 31. doi: 10.2147/JIR.S364303

PMCID:: PMC9635481

Abstract Article PDF–4.9M

Select item 940077112.

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?

Giacomo Aimar, Chiara Paratore, Clizia Zichi, Donatella Marino, Elisa Sperti, Andrea Caglio, Teresa Gamba, Francesca De Vita, Massimo Di Maio

Explor Target Antitumor Ther. 2021; 2(5): 448–464. Published online 2021 Oct 31. doi: 10.37349/etat.2021.00056

PMCID:: PMC9400771

Abstract Article PDF–1.8M

Select item 892845913.

Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma

Yunchao Wang, Xiaobo Yang, Dongxu Wang, Xu Yang, Yanyu Wang, Junyu Long, Jinxue Zhou, Zhenhui Lu, Yilei Mao, Xinting Sang, Mei Guan, Haitao Zhao

Front Oncol. 2022; 12: 785535. Published online 2022 Mar 3. doi: 10.3389/fonc.2022.785535

PMCID:: PMC8928459

Abstract Article PDF–1.3M

Select item 891448714.

A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma

Cecilia Monge, Erica C Pehrsson, Changqing Xie, Austin G Duffy, Donna Mabry, Bradford J Wood, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Anuradha Budhu, Sophie Wang, Mayank Tandon, Lichun Ma, Xin Wei Wang, Tim F Greten

Oncologist. 2022 Mar; 27(3): e273–e285. Published online 2022 Feb 19. doi: 10.1093/oncolo/oyab073

PMCID:: PMC8914487

Abstract Article PDF–24M

Select item 865634815.

Analysis of somatic copy number alterations in biliary tract carcinoma using a single nucleotide polymorphism array

Yoshihiro Shioi, Mitsumasa Osakabe, Naoki Yanagawa, Hiroyuki Nitta, Akira Sasaki, Tamotsu Sugai

Future Sci OA. 2022 Jan; 8(1): FSO766. Published online 2021 Nov 15. doi: 10.2144/fsoa-2021-0057

PMCID:: PMC8656348

Abstract Article PDF–909K

Select item 850732316.

Efficacy and Safety of First-Line Chemotherapies for Patients With Advanced Biliary Tract Carcinoma: A Systematic Review and Network Meta-Analysis

Yanfeng Jiang, Zhiming Zeng, Jie Zeng, Cuizhen Liu, Jinfeng Qiu, Ye Li, Jing Tang, Ning Mo, Lihua Du, Jie Ma

Front Oncol. 2021; 11: 736113. Published online 2021 Sep 28. doi: 10.3389/fonc.2021.736113

PMCID:: PMC8507323

Abstract Article PDF–5.1M

Select item 848749217.

Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids

Zhiwei Wang, Yinghao Guo, Yun Jin, Xiaoxiao Zhang, Hao Geng, Guangyuan Xie, Dan Ye, Yuanquan Yu, Daren Liu, Donger Zhou, Baizhou Li, Yan Luo, Shuyou Peng, Jiangtao Li

Cancer Cell Int. 2021; 21: 519. Published online 2021 Oct 2. doi: 10.1186/s12935-021-02219-w

PMCID:: PMC8487492

Abstract Article PDF–9.0M

Select item 841163618.

Apatinib for patients with metastatic biliary tract carcinoma refractory to standard chemotherapy: results from an investigator-initiated, open-label, single-arm, exploratory phase II study

Chenchen Wang, Mingzhu Huang, Qirong Geng, Wenhua Li, Jinjia Chang, Wei Tang, Weijian Guo

Ther Adv Med Oncol. 2021; 13: 17588359211039047. Published online 2021 Aug 31. doi: 10.1177/17588359211039047

PMCID:: PMC8411636

Abstract Article PDF–891K

Select item 836610119.

Gamma‐synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma

Yusuke Takemura, Hidenori Ojima, Go Oshima, Masahiro Shinoda, Yasushi Hasegawa, Minoru Kitago, Hiroshi Yagi, Yuta Abe, Shutaro Hori, Yoko Fujii‐Nishimura, Naoto Kubota, Yuki Masuda, Taizo Hibi, Michiie Sakamoto, Yuko Kitagawa

Cancer Med. 2021 Aug; 10(16): 5599–5613. Published online 2021 Jul 9. doi: 10.1002/cam4.4121

PMCID:: PMC8366101

Abstract Article PDF–2.3M

Select item 797830820.

Mutational spectrum and precision oncology for biliary tract carcinoma

Jianzhen Lin, Yinghao Cao, Xu Yang, Guangyu Li, Yang Shi, Dongxu Wang, Junyu Long, Yang Song, Jinzhu Mao, Fucun Xie, Yi Bai, Lei Zhang, Xiaobo Yang, Xueshuai Wan, Anqiang Wang, Mei Guan, Lin Zhao, Ke Hu, Jie Pan, Li Huo, Xin Lu, Yilei Mao, Xinting Sang, Henghui Zhang, Kai Wang, Xiaoyue Wang, Haitao Zhao

Theranostics. 2021; 11(10): 4585–4598. Published online 2021 Mar 4. doi: 10.7150/thno.56539

PMCID:: PMC7978308

Abstract Article PDF–2.9M

<< First< Prev

Page of 5

Next >Last >>

Supplemental Content

Filter your results:

All (99)
NIH grants (9)
Embargoed (0)

Manage Filters

Find related data

Recent activity

Clear Turn Off Turn On

PMC Articles for MedGen (Select 1648585) (99)
PMC
Advanced Bile Duct Carcinoma
Advanced Bile Duct Carcinoma

MedGen
Unresectable Extrahepatic Bile Duct Carcinoma
Unresectable Extrahepatic Bile Duct Carcinoma

MedGen
Unresectable Gallbladder Carcinoma
Unresectable Gallbladder Carcinoma

MedGen

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to: